{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:58:39Z","timestamp":1785859119399,"version":"3.56.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/ogx.0b013e31824bb538","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T04:31:18Z","timestamp":1332477078000},"page":"167-175","source":"Crossref","is-referenced-by-count":3,"title":["New Technologies for the Management of Pregestational Diabetes Mellitus"],"prefix":"10.1097","volume":"67","author":[{"given":"Aviva","family":"Lee-Parritz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210212","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/157339909788920893","article-title":". Pregnancy in type 2 diabetes mellitusproblems promises.","volume":"3","author":"McIntyre","year":"2009","journal-title":"Curr Diabetes Rev"},{"key":"R2-17-20210212","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2337\/dc09-1801","article-title":". Diabetes trends among delivery hospitalizations in the U.S., 1994-2004.","volume":"33","author":"Albrecht","year":"2010","journal-title":"Diabetes Care"},{"key":"R3-17-20210212","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1210\/jc.2009-1231","article-title":". Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis.","volume":"94","author":"Balsells","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-17-20210212","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2337\/dc07-2029","article-title":". Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes: results of the Yorkshire Registry of diabetes in children and young adults.","volume":"31","author":"Feltbower","year":"2008","journal-title":"Diabetes Care"},{"key":"R5-17-20210212","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.amjmed.2011.07.011","article-title":"Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities.","volume":"124","author":"Boucai","year":"2011","journal-title":"Am J Med"},{"key":"R7-17-20210212","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00125-010-1697-9","article-title":". Progression of diabetic retinopathy during pregnancyin women with type 2 diabetes.","volume":"53","author":"Rasmussen","year":"2010","journal-title":"Diabetologia"},{"key":"R8-17-20210212","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/diacare.19.10.1067","article-title":". Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency.","volume":"19","author":"Purdy","year":"1996","journal-title":"Diabetes Care"},{"key":"R9-17-20210212","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2337\/diacare.18.4.572","article-title":". Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion.","volume":"18","author":"Mogensen","year":"1995","journal-title":"Diabstes Care"},{"key":"R10-17-20210212","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/diacare.27.6.1458","article-title":". Diabetic somatic neuropathies (Technical Review).","volume":"27","author":"Boulton","year":"2004","journal-title":"Diabetes Care"},{"key":"R11-17-20210212","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ogc.2007.08.001","article-title":"Diabetic ketoacidosis in pregnancy.","volume":"34","author":"Parker","year":"2007","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R12-17-20210212","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2337\/dc08-9020","article-title":". Managing preexisting diabetes for pregnancy.","volume":"31","author":"Kitzmiller","year":"2008","journal-title":"Diabetes Care"},{"key":"R13-17-20210212","first-page":"E173","article-title":"Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose.","volume":"272","author":"Yang","year":"1997","journal-title":"Am J Physiol"},{"key":"R14-17-20210212","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2337\/diacare.19.5.514","article-title":". Pre-conception care of diabetes, congenital malformations, and spontaneous abortions.","volume":"19","author":"Kitzmiller","year":"1996","journal-title":"Diabetes Care"},{"key":"R17-17-20210212","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2393-10-63","article-title":". Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis.","volume":"10","author":"Wahabi","year":"2010","journal-title":"BMC Pregnancy Childbirth"},{"key":"R18-17-20210212","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2393-6-30","article-title":". Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies.","volume":"6","author":"Inkster","year":"2006","journal-title":"BMC Pregnancy and Childbirth"},{"key":"R19-17-20210212","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/0002-9378(81)90731-6","article-title":"Carbohydrate metabolism in pregnancy: XVII, diurnal profiles of plasma glucose, insulin, free fatty acids, triglycerides, cholesterol, and individual amino acids in late normal pregnancy.","volume":"140","author":"Phelps","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"R20-17-20210212","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2337\/diacare.24.8.1319","article-title":". Third-trimester maternal glucose levels from diurnal profiles in nondiabetic pregnancies: correlation with sonographic parameters of fetal growth.","volume":"24","author":"Parretti","year":"2001","journal-title":"Diabetes Care"},{"key":"R21-17-20210212","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/01.AOG.0000129239.82126.a1","article-title":". Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy.","volume":"104","author":"Yogev","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R22-17-20210212","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1515\/jpm.2010.142","article-title":". Normal fasting plasma glucose levels during pregnancy: a hospital-based study.","volume":"39","author":"Riskin-Mashiah","year":"2011","journal-title":"J Perinat Med"},{"key":"R23-17-20210212","first-page":"646","article-title":"O, Levy J, Brustman L, et al..","volume":"161","year":"1989","journal-title":"Glycemic control in gestational diabetes mellitushow tight is tight enough: small for gestational age versus large for gestational age Am J Obstet Gynecol"},{"key":"R24-17-20210212","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s001250051565","article-title":"Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type 1 diabetes mellitus.","volume":"43","author":"Hiilesmaa","year":"2000","journal-title":"Diabetologia"},{"key":"R25-17-20210212","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2337\/diacare.24.10.1739","article-title":". Pregnancy outcome in type 1 diabetic women with microalbuminuria.","volume":"24","author":"Ekbom","year":"2001","journal-title":"Diabetes Care"},{"key":"R26-17-20210212","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2337\/dc08-1526","article-title":"Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy. Effects of intensified antihypertensive therapy.","volume":"32","author":"Nielsen","year":"2009","journal-title":"Diabetes Care"},{"key":"R27-17-20210212","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","article-title":". Major congenital malformations after first-trimester exposure to ACE inhibitors.","volume":"354","author":"Cooper","year":"2006","journal-title":"N Engl J Med"},{"key":"R28-17-20210212","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1124\/dmd.108.024984","article-title":". Clonidine pharmacokinetics in pregnancy.","volume":"37","author":"Buchanan","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"R29-17-20210212","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1464-5491.2005.01473.x","article-title":". Insulin aspart improves meal time glycaemic control in patients with type 2 diabetes: a randomized, stratified, double-blind and cross-over trial.","volume":"22","author":"Perriello","year":"2005","journal-title":"Diabet Med"},{"key":"R30-17-20210212","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/archinte.1997.00440320157015","article-title":"; for the Multicenter Insulin Lispro Study Group. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus.","volume":"157","author":"Anderson","year":"1997","journal-title":"Arch Intern Med"},{"key":"R31-17-20210212","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ajog.2007.08.005","article-title":". Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects.","volume":"198","author":"Hod","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R32-17-20210212","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/dc06-1887","article-title":"; on behalf of the Insulin Aspart Pregnancy Study Group. Maternal glycemic control and hypoglycemia in type 1 diabetes pregnancy: a randomized trial of insulin aspart vs. human insulin in 322 pregnant women.","volume":"30","author":"Mathiesen","year":"2007","journal-title":"Diabetes Care"},{"key":"R33-17-20210212","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1445-5994.2005.00902.x","article-title":"Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting glucose levels during intensive insulin therapy.","volume":"35","author":"Fulcher","year":"2005","journal-title":"Intern Med J"},{"key":"R34-17-20210212","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.diabres.2008.04.007","article-title":"Long-acting insulin analogs versus NPH human insulin in type 2 diabetes: a meta-analysis.","volume":"81","author":"Monami","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"R35-17-20210212","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2337\/diabetes.49.6.999","article-title":". Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.","volume":"49","author":"Kurtzhals","year":"2000","journal-title":"Diabetes"},{"key":"R36-17-20210212","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2337\/dc09-1045","article-title":". Insulin glargine safety in pregnancy: a transplacental transfer study.","volume":"33","author":"Pollex","year":"2010","journal-title":"Diabetes Care"},{"key":"R37-17-20210212","first-page":"1","article-title":"Insulin glargine: use in pregnancy.","volume":"25","author":"Pantalone","year":"2011","journal-title":"Endocr Pract"},{"key":"R38-17-20210212","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2337\/diacare.26.4.1193","article-title":". Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro.","volume":"26","author":"Loukovaara","year":"2003","journal-title":"Diabetes Care"},{"key":"R39-17-20210212","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.fertnstert.2006.02.098","article-title":"Pregnancy outcome after first trimester exposure to metformin: a meta analysis.","volume":"86","author":"Gilbert","year":"2006","journal-title":"Fertil Steril"},{"key":"R40-17-20210212","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/humrep\/deh263","article-title":". Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.","volume":"19","author":"Glueck","year":"2004","journal-title":"Hum Reprod"},{"key":"R41-17-20210212","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","article-title":"; MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes.","volume":"358","author":"Rowan","year":"2008","journal-title":"N Engl J Med"},{"key":"R42-17-20210212","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0002-9378(91)90421-M","article-title":". Insignificant transfer of glyburide occurs across the human placenta.","volume":"165","author":"Elliott","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"R43-17-20210212","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2337\/diacare.14.8.724","article-title":". Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans.","volume":"14","author":"Groop","year":"1991","journal-title":"Diabetes Care"},{"key":"R44-17-20210212","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","article-title":". A comparison of glyburide and insulin in women with gestational diabetes mellitus.","volume":"343","author":"Langer","year":"2000","journal-title":"N Engl J Med"},{"key":"R45-17-20210212","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bpobgyn.2010.10.018","article-title":"Oral hypoglycaemic agents during pregnancy: the evidence for effectiveness and safety.","volume":"25","author":"Nicholson","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R46-17-20210212","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jc.2008-1415","article-title":". Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion vs. multiple daily injections.","volume":"94","author":"Fatourechi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-17-20210212","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.diabet.2011.02.002","article-title":"; the IGCSIIP (Italian Group for Continuous Subcutaneous Insulin Infusion in Pregnancy). Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).","volume":"37","author":"Bruttomesso","year":"2011","journal-title":"Diabetes Metab"},{"key":"R49-17-20210212","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ajog.2007.03.062","article-title":". Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and meta-analysis or randomized, controlled trials.","volume":"197","author":"Mukhopadhyay","year":"2007","journal-title":"Am J Obstet Gynecol"}],"container-title":["Obstetrical & Gynecological Survey"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001665-201203000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:05:38Z","timestamp":1785855938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006254-201203000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ogx.0b013e31824bb538","relation":{},"ISSN":["0029-7828"],"issn-type":[{"value":"0029-7828","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}